Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Single-cell OMICS-informed in vitro models of human development

Project description

Learning from the mammalian embryo – towards in vitro models of human development

Cell-based therapies are revolutionising medicine. While human pluripotent stem cells (hPSCs) are promising due to their unlimited self-renewal and ability to become any cell type, they often underperform in transplantation assays. The ERC-funded CatchTheWave project will tap into single-cell transcriptomics of mammalian embryonic development to enhance hPSC differentiation protocols and generate haematopoietic stem cells (HSCs) in vitro. The project will also analyse variability in embryoid body differentiation and identify key genes influencing HSC emergence through targeted genetic screens and mouse transplantation studies. Ultimately, the project seeks to establish a reliable method for producing hPSC-derived HSCs for clinical applications and to create a blueprint for hPSC differentiation protocol optimisation based on in vivo embryonic development.

Objective

From immunotherapy to restoring neural function in Parkinson’s disease, cell-based therapies are shaping medicine. Human pluripotent stem cells (hPSCs) could be an invaluable resource, given their unlimited in vitro self-renewal and ability to differentiate into any cell-type. However, in vitro hPSC-derived cells show defective performance in transplantation assays. Using the long-sought in vitro production of hematopoietic stem cells (HSCs) as a model, I propose a strategy to assess and rectify the accuracy of hPSC differentiation protocols in recapitulating embryonic cell fate decision processes:
AIM1 Establish an analysis workflow to systematically compare hPSC-derived developmental trajectories with in vivo mammalian embryonic development, using time-resolved single-cell RNA sequencing (scRNAseq) data. I will benchmark an hPSC differentiation dataset featuring emergence of an HSC signature against a range of published developmental datasets, including both human fetal samples and animal models.
AIM2 Probe intrinsic variability of embryoid body (EB)-based hPSC differentiation by integrating cell-type composition (by scRNAseq), time-lapse secretome and morphology of 24 individual EBs. I will thus identify cell-types and secreted factors enriched in the rare EBs comprising an HSC signature.
AIM3 Determine the functional relevance of genes identified as in vitro de-regulated (Aim 1) and/or associated with HSC signature emergence in vitro (Aim 2) using a targeted genetic screen in hPSC differentiation followed by robust transplantation in immunodeficient mice.
AIM4 Define the cell autonomous role of genes with confirmed functional relevance for production of HSCs from hPSC (Aim 3) by multiomic profiling of mosaic EBs.
By leveraging the rise in single-cell developmental Atlases, I will obtain robust generation of hPSC-derived HSCs through innovative declinations of EB-based hPSC differentiation, establishing a new paradigm towards clinical translation of hPSCs.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-STG

See all projects funded under this call

Host institution

GOETEBORGS UNIVERSITET
Net EU contribution
€ 1 500 000,00
Address
VASAPARKEN
405 30 Goeteborg
Sweden
Region
Södra Sverige Västsverige Västra Götalands län
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 500 000,00

Beneficiaries (1)